Summary
- Profile Type
- Technology request
- POD Reference
- TRGB20250331014
- Term of Validity
- 31 March 2025 - 31 March 2026
- Company's Country
- United Kingdom
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- Globally, hundreds of millions suffer from gut disorders, with irritable bowel syndrome (IBS) affecting over 10 million people in the UK alone. GutSee Health is revolutionising gut disorder treatment by merging cutting-edge science with advanced AI modelling. Their groundbreaking AI-Discovery platform transforms vast human genetic data into disease signatures and therapy targets. Through their unique and targeted microbiome therapy, they look to restore a healthy gut balance, eliminating symptom
- Full Description
-
GutSee Health is a London-based biotech company revolutionising gut disorder treatments by combining advanced AI modeling with innovative microbiome therapies. As a data-driven company, they are actively seeking IBS and IBD datasets to power their AI discovery platform. They welcome collaborations with academic researchers and enterprises that have datasets on irritable bowel syndrome (IBS) and Inflammatory Bowel Disease (IBD).
Partnership opportunities include patient studies, co-developing R&D projects, joint research publications, academic secondments, and PhD fellowship programs. For example, this could be achieved through applying for research and innovation funding opportunities in collaboration such as Horizon Europe calls or more specific sectorial funding calls. - Technical Specification or Expertise Sought
- Access to data, including metagenomic, metabolomic, and patient data related to IBS/IBD or relevant gut disorders.
- Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
- Ideal partners would be able to provide access to available data sought, as well as offer the potential to: partner on patient studies, co-developing R&D projects, publishing joint research, facilitating academic secondments, and exploring establishing PhD fellowship programs.
- Type and Size of Partner
- SME <=10
- SME 11-49
- SME 50 - 249
- Big company
- Other
- University
- R&D Institution
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
Dissemination
- Technology keywords
- 06003003 - Population genetics
- 06003002 - Gene Expression, Proteome Research
- 06003001 - Bioinformatics
- 06005003 - Health information management
- Market keywords
- 05003001 - Therapeutic services
- 05001005 - Molecular diagnosis
- 05001001 - Diagnostic services
- Targeted countries
- All countries